{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-017342","form_type":"8-K","ticker":"IVF","cik":"0001417926","company_name":"INVO Fertility, Inc.","filed_at":"2023-05-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.785252+00:00","generated_at":"2026-06-15T00:54:11.337767+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"INVO Bioscience Q1 2023 revenue up 114% to $348k; gross margin improves to 79%","bullets":["Revenue $348,025 (+114% YoY); consolidated clinic revenue $297,381 (+181% YoY).","Gross margin 79% vs 60% in Q1 2022; adjusted EBITDA loss narrowed to $(1.7)M from $(2.0)M.","All-clinic combined revenue $646,707 (+108% YoY); existing centers nearing break-even.","Acquisition of Wisconsin Fertility Institute for $10M payable over 3 years; closing expected Q2 2023.","Raised ~$3M in registered direct offering; cash balance $2.2M as of March 31, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-017342","json":"https://secwatch.observer/filing/0001493152-23-017342.json","markdown":"https://secwatch.observer/filing/0001493152-23-017342.md","text":"https://secwatch.observer/filing/0001493152-23-017342.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223017342/0001493152-23-017342-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223017342/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T00:54:11.337767+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ccdd9b2d7f9f84b7bc5a7b2364ef66984f4fc895","claim":"INVO Fertility, Inc. reported three months ended March 31, 2023 results: revenue $348,025.","evidence_excerpt":"Revenue for the three months ended March 31, 2023, was $348,025 compared to $162,598 for the three months ended March 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417926/000149315223017342/0001493152-23-017342-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"three months ended March 31, 2023"},{"label":"Revenue","value":"$348,025"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}